<VariationArchive VariationID="1476999" VariationName="NM_004586.3(RPS6KA3):c.2142_2145dup (p.Pro716fs)" VariationType="Duplication" Accession="VCV001476999" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1417064" VariationID="1476999">
      <GeneList>
        <Gene Symbol="RPS6KA3" FullName="ribosomal protein S6 kinase A3" GeneID="6197" HGNC_ID="HGNC:10432" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp22.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="20149911" stop="20267097" display_start="20149911" display_stop="20267097" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="20168028" stop="20284749" display_start="20168028" display_stop="20284749" Strand="-" />
          </Location>
          <OMIM>300075</OMIM>
          <Haploinsufficiency last_evaluated="2022-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPS6KA3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPS6KA3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004586.3(RPS6KA3):c.2142_2145dup (p.Pro716fs)</Name>
      <CanonicalSPDI>NC_000023.11:20155475:TGACTGA:TGACTGACTGA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="20155475" stop="20155476" display_start="20155475" display_stop="20155476" variantLength="4" positionVCF="20155475" referenceAlleleVCF="G" alternateAlleleVCF="GTGAC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="20173593" stop="20173594" display_start="20173593" display_stop="20173594" variantLength="4" positionVCF="20173593" referenceAlleleVCF="G" alternateAlleleVCF="GTGAC" />
      </Location>
      <ProteinChange>P716fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.20155479_20155482dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.20155479_20155482dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007488.1" sequenceAccession="NG_007488" sequenceVersion="1" change="g.116154_116157dup">
            <Expression>NG_007488.1:g.116154_116157dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004586.3" sequenceAccession="NM_004586" sequenceVersion="3" change="c.2142_2145dup" MANESelect="true">
            <Expression>NM_004586.3:c.2142_2145dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004577.1" sequenceAccession="NP_004577" sequenceVersion="1" change="p.Pro716fs">
            <Expression>NP_004577.1:p.Pro716fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.20173597_20173600dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.20173597_20173600dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2148622591" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004586.3(RPS6KA3):c.2142_2145dup (p.Pro716fs) AND multiple conditions" Accession="RCV002014963" Version="3">
        <ClassifiedConditionList TraitSetID="10232">
          <ClassifiedCondition DB="MedGen" ID="C0265252">Coffin-Lowry syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0796225">Intellectual disability, X-linked 19</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10094187</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16879200</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="10232" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="823" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Coffin-Lowry syndrome</ElementValue>
                <XRef ID="Coffin-Lowry+Syndrome/1709" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010561" DB="MONDO" />
                <XRef ID="15182000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">COFFIN-LOWRY SYNDROME, MILD</ElementValue>
                <XRef Type="Allelic variant" ID="300075.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation with osteocartilaginous abnormalities</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Coffin syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CLS</ElementValue>
                <XRef Type="MIM" ID="303600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6123" />
                <XRef ID="6123" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Coffin-Lowry syndrome (CLS) is usually characterized by severe-to-profound intellectual disability in males; less severely impaired individuals have been reported. Neuropsychiatric concerns can include behavioral problems, loss of strength, progressive spasticity or paraplegia, sleep apnea, or stroke. Stimulus-induced drop attacks (SIDAs) in which unexpected tactile or auditory stimuli or excitement triggers a brief collapse but no loss of consciousness are present in approximately 20% of affected individuals. Typically SIDAs begin between mid-childhood and the teens. Characteristic facial features may be more apparent with age. Upper-extremity differences may be subtle and include short, soft, fleshy hands with tapered fingers as well as fleshy forearms. Progressive kyphoscoliosis is one of the most difficult aspects of long-term care. Affected females tend to have intellectual disability in the mild-to-moderate range and may also have the typical facial, hand, and skeletal findings noted in males.</Attribute>
                <XRef ID="NBK1346" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301520</ID>
                <ID Source="BookShelf">NBK1346</ID>
              </Citation>
              <XRef ID="192" DB="Orphanet" />
              <XRef ID="C0265252" DB="MedGen" />
              <XRef ID="MONDO:0010561" DB="MONDO" />
              <XRef Type="MIM" ID="303600" DB="OMIM" />
            </Trait>
            <Trait ID="10895" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 19</ElementValue>
                <XRef Type="MIM" ID="300844" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300075.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300075.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300075.0020" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, X-linked 19</ElementValue>
                <XRef ID="MONDO:0010447" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">XLID19</ElementValue>
                <XRef Type="MIM" ID="300844" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="22687" />
                <XRef ID="22687" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301520</ID>
                <ID Source="BookShelf">NBK1346</ID>
              </Citation>
              <XRef ID="777" DB="Orphanet" />
              <XRef ID="C0796225" DB="MedGen" />
              <XRef ID="MONDO:0010447" DB="MONDO" />
              <XRef Type="MIM" ID="300844" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4280894" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="13792367|MedGen:C0265252;C0796225" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002258040" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10094187</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16879200</ID>
          </Citation>
          <Comment>This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the RPS6KA3 protein in which other variant(s) (p.Arg729Trp) have been determined to be pathogenic (PMID: 10094187, 16879200). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1476999). This variant has not been reported in the literature in individuals affected with RPS6KA3-related conditions. This sequence change creates a premature translational stop signal (p.Pro716Valfs*19) in the RPS6KA3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 25 amino acid(s) of the RPS6KA3 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPS6KA3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.20173593_20173594insTGAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265252" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0796225" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4280894" TraitType="Disease" MappingType="XRef" MappingValue="C0265252" MappingRef="MedGen">
        <MedGen CUI="C0265252" Name="Coffin-Lowry syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4280894" TraitType="Disease" MappingType="XRef" MappingValue="C0796225" MappingRef="MedGen">
        <MedGen CUI="C0796225" Name="Intellectual disability, X-linked 19" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

